AR028270A1 - Un compuesto que comprende derivados de imidazol con actividad antiinflamatoria y el procedimiento para preparar el mismo - Google Patents
Un compuesto que comprende derivados de imidazol con actividad antiinflamatoria y el procedimiento para preparar el mismoInfo
- Publication number
- AR028270A1 AR028270A1 ARP010101304A ARP010101304A AR028270A1 AR 028270 A1 AR028270 A1 AR 028270A1 AR P010101304 A ARP010101304 A AR P010101304A AR P010101304 A ARP010101304 A AR P010101304A AR 028270 A1 AR028270 A1 AR 028270A1
- Authority
- AR
- Argentina
- Prior art keywords
- prepare
- procedure
- compound
- same
- inflammatory activity
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/06—Antiabortive agents; Labour repressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/68—Halogen atoms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Endocrinology (AREA)
- Pulmonology (AREA)
- Biomedical Technology (AREA)
- Reproductive Health (AREA)
- Urology & Nephrology (AREA)
- Heart & Thoracic Surgery (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- Physical Education & Sports Medicine (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Hospice & Palliative Care (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Diabetes (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ES200000707A ES2159489B1 (es) | 2000-03-23 | 2000-03-23 | Nuevos derivados de imidazol con actividad antiinflamatoria. |
Publications (1)
Publication Number | Publication Date |
---|---|
AR028270A1 true AR028270A1 (es) | 2003-04-30 |
Family
ID=8492829
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP010101304A AR028270A1 (es) | 2000-03-23 | 2001-03-20 | Un compuesto que comprende derivados de imidazol con actividad antiinflamatoria y el procedimiento para preparar el mismo |
Country Status (12)
Country | Link |
---|---|
US (1) | US6743816B2 (es) |
EP (1) | EP1270559A1 (es) |
JP (1) | JP2003528086A (es) |
KR (1) | KR20020087942A (es) |
AR (1) | AR028270A1 (es) |
AU (1) | AU2001239311A1 (es) |
BR (1) | BR0109445A (es) |
CA (1) | CA2403732A1 (es) |
ES (1) | ES2159489B1 (es) |
MX (1) | MXPA02009322A (es) |
NO (1) | NO20024504L (es) |
WO (1) | WO2001070704A1 (es) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2184633B1 (es) * | 2001-08-07 | 2004-08-01 | J. URIACH & CIA, S.A. | Procedimiento para la preparacion de derivados de 4-(imidazol-1-il) bencenosulfonamida. |
GB0225548D0 (en) | 2002-11-01 | 2002-12-11 | Glaxo Group Ltd | Compounds |
GB0306329D0 (en) * | 2003-03-19 | 2003-04-23 | Glaxo Group Ltd | Compounds |
GB0323585D0 (en) * | 2003-10-08 | 2003-11-12 | Glaxo Group Ltd | Compounds |
CN102464652B (zh) * | 2010-11-02 | 2013-08-28 | 北京欧博方医药科技有限公司 | 咪唑衍生物、制备方法及用途 |
CN104926797B (zh) * | 2014-06-10 | 2019-04-16 | 北京元博方医药科技有限公司 | 呋喃酮衍生物、制备方法及用途 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3901908A (en) * | 1970-12-28 | 1975-08-26 | Ciba Geigy Corp | 2-alkyl- and 2-cycloalkyl-4,5-bis-phenyl-imidazoles |
IT1168008B (it) * | 1981-07-31 | 1987-05-20 | Zambon Spa | Imidazol-eteri ed ester, procedimenti per prepararli e composizioni farmaceutiche che li contengono |
US5616601A (en) * | 1994-07-28 | 1997-04-01 | Gd Searle & Co | 1,2-aryl and heteroaryl substituted imidazolyl compounds for the treatment of inflammation |
US5620999A (en) * | 1994-07-28 | 1997-04-15 | Weier; Richard M. | Benzenesulfonamide subtituted imidazolyl compounds for the treatment of inflammation |
AR024222A1 (es) * | 1998-10-16 | 2002-09-25 | Palau Pharma Sa | Imidazoles con actividad antiinflamatoria un procedimiento para su preparacion y composiciones farmaceuticas que lo contienen |
-
2000
- 2000-03-23 ES ES200000707A patent/ES2159489B1/es not_active Expired - Fee Related
-
2001
- 2001-03-20 AR ARP010101304A patent/AR028270A1/es unknown
- 2001-03-22 BR BR0109445-9A patent/BR0109445A/pt not_active IP Right Cessation
- 2001-03-22 KR KR1020027012555A patent/KR20020087942A/ko not_active Application Discontinuation
- 2001-03-22 WO PCT/ES2001/000114 patent/WO2001070704A1/es not_active Application Discontinuation
- 2001-03-22 MX MXPA02009322A patent/MXPA02009322A/es unknown
- 2001-03-22 JP JP2001568914A patent/JP2003528086A/ja active Pending
- 2001-03-22 AU AU2001239311A patent/AU2001239311A1/en not_active Abandoned
- 2001-03-22 US US10/239,359 patent/US6743816B2/en not_active Expired - Fee Related
- 2001-03-22 EP EP01913898A patent/EP1270559A1/en not_active Withdrawn
- 2001-03-22 CA CA002403732A patent/CA2403732A1/en not_active Abandoned
-
2002
- 2002-09-20 NO NO20024504A patent/NO20024504L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
WO2001070704A1 (es) | 2001-09-27 |
MXPA02009322A (es) | 2003-03-12 |
AU2001239311A1 (en) | 2001-10-03 |
CA2403732A1 (en) | 2002-09-20 |
EP1270559A1 (en) | 2003-01-02 |
ES2159489B1 (es) | 2002-04-16 |
KR20020087942A (ko) | 2002-11-23 |
JP2003528086A (ja) | 2003-09-24 |
US6743816B2 (en) | 2004-06-01 |
ES2159489A1 (es) | 2001-10-01 |
US20030176481A1 (en) | 2003-09-18 |
BR0109445A (pt) | 2003-06-03 |
NO20024504D0 (no) | 2002-09-20 |
NO20024504L (no) | 2002-11-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20020275L (no) | Imidazoimidazoler og -triazoler som anti-inflammatoriske midler | |
EE200200295A (et) | Adamantaani derivaadid | |
NO20031869D0 (no) | Antiinflammatoriske midler | |
ECSP055888A (es) | Derivados de aril-quinazolin/aril-2-amino-fenil metanona que promueven la liberación de la hormona paratiroides. | |
IT1314074B1 (it) | Albero telescopico | |
ATE540013T1 (de) | Naphthalinderivate | |
DK1242364T3 (da) | Adamantanderivater | |
LV12624B (lv) | Tienilazolilalkosietanamini to iegusanas panemiens un pielietojums medikamentu legusana | |
CY2011009I1 (el) | Νεες ιμιδαζολες με αντιφλογιστικη δραστικοτητα | |
NO20002572D0 (no) | Flerlags-struktur | |
DE60036518D1 (de) | Axialturbinen | |
NO20022624L (no) | Heterocyklo-alkylsulfonylderivater som anti- inflammatoriske/smertestillende midler | |
DE69901673T2 (de) | Befestigungsmittel | |
NO20020161D0 (no) | Vitamin D3-analoger | |
DE60039190D1 (de) | Massnahmen welche die effekte einer kalorischen beschränkung nachahmen | |
DK1086097T3 (da) | Sulfonylbenzenforbindelser som anti-inflammatoriske/analgetiske midler | |
DE60029393D1 (de) | Bolzen | |
DE59912034D1 (de) | Axialturbine | |
AR028270A1 (es) | Un compuesto que comprende derivados de imidazol con actividad antiinflamatoria y el procedimiento para preparar el mismo | |
PT1189929E (pt) | Inibidores do factor viia | |
DE60041995D1 (de) | Wabenkörperstruktur | |
DE60018967D1 (de) | Inierzierbare valnemulin formulierung | |
DE10194907T1 (de) | Gewinde-Klemmkonstruktion | |
AR024282A1 (es) | Compuestos derivdos de piperidin-etanosulfonil, su empleo, procedimiento para prepararlos y medicamentos que los contienen | |
PT1135140E (pt) | Utilizacao de ibandronato para a promocao da integracao ossea de endoproteses |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |